Turn Therapeutics (TTRX) Total Liabilities (2024 - 2026)

Turn Therapeutics' Total Liabilities history runs 3 years deep, the most recent figure standing at $12.5 million for Q1 2026.

• On a quarterly basis, Total Liabilities changed N/A year-over-year to $12.5 million in Q1 2026; TTM through Mar 2026 was $12.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.5 million, up 235.78% from the prior year.
• Total Liabilities improved to $12.5 million in Q1 2026 per TTRX's latest filing, from $7.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $12.5 million in Q1 2026 and bottomed at $2.2 million in Q4 2024.
• The 3-year median for Total Liabilities is $5.6 million (2025), against an average of $6.5 million.
• Biggest YoY gain for Total Liabilities was 235.78% in 2025; the steepest drop was 235.78% in 2025.
• Year by year, Total Liabilities stood at $2.2 million in 2024, then soared by 235.78% to $7.5 million in 2025, then soared by 67.57% to $12.5 million in 2026.
• Per Business Quant, the three latest TTRX Total Liabilities figures stand at $12.5 million (Q1 2026), $7.5 million (Q4 2025), and $3.8 million (Q3 2025).